Supreme Court Eyes Glaxo's Paxil Appeal

Law360, New York (January 9, 2006, 12:00 AM EST) -- In a fresh sign that intellectual property matters will weigh heavily at the U.S. Supreme Court this year, justices have asked the Bush administration's solicitor general for advice while considering the appeal of U.K. drug maker GlaxoSmithKline Plc over its antidepressant Paxil.

Glaxo’s subsidiary SmithKline Beecham Corp. sued Canadian generic drug maker Apotex Inc. in 1998 over its attempt to make a generic version of the popular drug. The suit was filed in the U.S. District Court for the Northern District of Illinois, which ruled in...
To view the full article, register now.